Pacific Biosciences of California (PACB) News
NASDAQ: PACBHealthcareMedical DevicesUSD
2.33+0.03 (+1.30%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
PACB news summary
We found 2 recent headlines mentioning Pacific Biosciences of California (PACB): 0 in the past week and 0 in the past 30 days, most often from Nasdaq. For price context, PACB is up 1.30% at $2.33. The most recent story, "Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?", was published by Nasdaq on Sep 4, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Pacific Biosciences of California headlines
- Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.NasdaqPACB, EW
- MDLN Gets FDA Warning for Quality Lapses in Angiographic SyringesMDLN faces FDA warning over cGMP lapses in angiographic syringes, citing weak quality controls, CAPA gaps and design flaws despite escalating share price.NasdaqGMED, PACB, BDSX, MDLN